Page last updated: 2024-08-24

arctigenin and Bile Duct Cancer

arctigenin has been researched along with Bile Duct Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Janthamala, S; Jusakul, A; Kimawaha, P; Klanrit, P; Kongpetch, S; Loilome, W; Namwat, N; Techasen, A	1

Other Studies

1 other study(ies) available for arctigenin and Bile Duct Cancer

Article	Year
Arctigenin inhibits cholangiocarcinoma progression by regulating cell migration and cell viability via the N-cadherin and apoptosis pathway. Naunyn-Schmiedeberg's archives of pharmacology, 2021, Volume: 394, Issue:10 Topics: Antigens, CD; Antineoplastic Agents, Phytogenic; Apoptosis; Bile Duct Neoplasms; Biomarkers, Tumor; Cadherins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cholangiocarcinoma; Disease Progression; Female; Furans; Humans; Lignans; Male; Middle Aged; Prognosis	2021

Article

Year

Arctigenin inhibits cholangiocarcinoma progression by regulating cell migration and cell viability via the N-cadherin and apoptosis pathway.

Naunyn-Schmiedeberg's archives of pharmacology, 2021, Volume: 394, Issue:10

Topics: Antigens, CD; Antineoplastic Agents, Phytogenic; Apoptosis; Bile Duct Neoplasms; Biomarkers, Tumor; Cadherins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cholangiocarcinoma; Disease Progression; Female; Furans; Humans; Lignans; Male; Middle Aged; Prognosis

2021